Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of Jake Leach to president, in addition to his ...

DexCom (DXCM) shares have put together an encouraging short-term bounce as the company maps out a multi-year growth algorithm ...

DexCom DXCM recently announced the launch of Dexcom Flex, a new continuous glucose monitoring (CGM) system designed for ...

During Dexcom Investor Day, CEO Jake Leach announced the company's newest CGM monitor, G8, which utilizes technology that ...

Dexcom, the locally based maker of continuous glucose monitors for diabetes patients, is projecting billion-dollar growth into 2030, and San Diego stands to profit. The medtech company invested more ...

Dexcom shares plunged on disappointing revenue and weak guidance. The stock was down 13% for the year as of Thursday's close. Dexcom makes continuous glucose monitors for patients with diabetes. In ...

DexCom (NASDAQ:DXCM) used its 2026 Investor Day to outline a long-range plan centered on new product launches, broader ...

May 14 (Reuters) - Medical device maker DexCom said on Thursday it has agreed with activist investor Elliott Investment Management to add two independent directors to the company's board and revamp a ...

“This small thing,” Nick Jonas says while holding the all-new Dexcom G7 Continuous Glucose Monitoring (CGM) system in his hand at the start of the new commercial for Super Bowl LVII. With a snap of ...